Neuromodulation and associated systems and methods for the treatment of sexual dysfunction
Methods for treating erectile dysfunction with therapeutic neuromodulation and associated systems and methods are disclosed herein. Erectile dysfunction can be characterized by the inability to develop and/or maintain an erection during sexual arousal or activity. One aspect of the present technology is directed to methods that at least partially inhibit sympathetic neural activity in nerves innervating the penis of a patient. Sympathetic drive in the patient can thereby be reduced in a manner that treats the patient for erectile dysfunction. Sympathetic nerve activity can be modulated along afferent and/or efferent pathways. The modulation can be achieved, for example, using an intravascularly positioned catheter carrying a therapeutic assembly, e.g., a therapeutic assembly configured to use electrically-induced, thermally-induced, and/or chemically-induced approaches to modulate the nerves.
1. A method, comprising:
introducing a neuromodulation assembly at a distal portion of a treatment device proximate to a dorsal nerve of a penis of a human patient diagnosed with erectile dysfunction or low libido, wherein introducing the neuromodulation assembly comprises extracorporeally positioning the neuromodulation assembly on penile tissue;
partially disrupting function of the dorsal nerve by applying thermal energy to the dorsal nerve via the neuromodulation assembly, wherein thermal energy is applied via the neuromodulation assembly through penile skin; and
removing the neuromodulation assembly from the patient after treatment,
wherein partial disruption of the function of the dorsal nerve therapeutically treats the diagnosed erectile dysfunction or low libido.
2. The method of claim 1 wherein the patient is diagnosed with low libido, and wherein partial disruption of the function of the dorsal nerve reverses low libido in the patient.
3. The method of claim 1 wherein partially disrupting function of the dorsal nerve by applying thermal energy comprises at least partially ablating the dorsal nerve via thermal energy from the neuromodulation assembly.
4. The method of claim 1 wherein partially disrupting function of the dorsal nerve in a manner that therapeutically treats the diagnosed erectile dysfunction or low libido comprises increasing a frequency of penile erections in the patient.
5. The method of claim 4 wherein increasing a frequency of penile erections in the patient is self-reported by the patient within about three months to about 12 months after reducing sympathetic neural activity in the patient.
6. The method of claim 4 wherein increasing a frequency of penile erections is assessed using a nocturnal penile tumescence test.
7. The method of claim 1 wherein partially disrupting function of the dorsal nerve in a manner that therapeutically treats the diagnosed erectile dysfunction or low libido comprises reducing a number of incidences where the patient reports impotence or premature loss of erection by at least about 20%.
8. The method of claim 1 wherein partially disrupting function of the dorsal nerve in a manner that therapeutically treats the diagnosed erectile dysfunction or low libido comprises reducing an average patient-perceived or clinician-observed frequency of impotence or premature detumescence during sexual activity within about three months to about 12 months after reducing sympathetic neural activity in the patient.
9. The method of claim 1 wherein partially disrupting function of the dorsal nerve by applying thermal energy to the dorsal nerve via the neuromodulation assembly comprises applying ultrasound energy via the neuromodulation assembly.